Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Kishan Bhakta"'
Autor:
Ozlen Balcioglu, Richard E. Heinz, David W. Freeman, Brooke L. Gates, Berhane M. Hagos, Evan Booker, Elnaz Mirzaei Mehrabad, Hyrum T. Diesen, Kishan Bhakta, Supraja Ranganathan, Masami Kachi, Mathias Leblanc, Peter C. Gray, Benjamin T. Spike
Publikováno v:
Breast Cancer Research, Vol 22, Iss 1, Pp 1-14 (2020)
Abstract Background CRIPTO is a multi-functional signaling protein that promotes stemness and oncogenesis. We previously developed a CRIPTO antagonist, ALK4L75A-Fc, and showed that it causes loss of the stem cell phenotype in normal mammary epithelia
Externí odkaz:
https://doaj.org/article/c3087deb5d704acbbb79917f2e2e47ce
Autor:
Farhana Runa, Luke Tomaneng, Yvess Adamian, Nathan Cox, Albert-Fred Aquino, Matthew Wallace, Carolina Gonzalez, Kishan Bhakta, Malachia Hoover, Laurelin Wolfenden, Jonathan D. Humphries, Martin J. Humphries, Michael Boyce, Jonathan A. Kelber
Publikováno v:
Cancer Research. 82:2414-2414
Pancreatic ductal adenocarcinoma (PDAC) is associated with very poor outcomes - fewer than 10 percent of patients survive beyond five years after diagnosis. The primary hurdles facing PDAC patients and clinicians are early dissemination, a lack of th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b2aa31d4e9df6a93a8d2aa38502528b7
https://doi.org/10.1158/1538-7445.am2022-2414
https://doi.org/10.1158/1538-7445.am2022-2414
Autor:
Berhane M. Hagos, Brooke L. Gates, David W. Freeman, Masami Kachi, Benjamin T. Spike, Kishan Bhakta, Elnaz Mirzaei Mehrabad, Hyrum T Diesen, Supraja Ranganathan, Mathias Leblanc, Ozlen Balcioglu, Evan Booker, Peter C. Gray, Richard E. Heinz
Publikováno v:
Breast Cancer Research, Vol 22, Iss 1, Pp 1-14 (2020)
Background CRIPTO is a multi-functional signaling protein that promotes stemness and oncogenesis. We previously developed a CRIPTO antagonist, ALK4L75A-Fc, and showed that it causes loss of the stem cell phenotype in normal mammary epithelia suggesti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::259a122931cac7e4953c13e3f9e16105
https://doi.org/10.1186/s13058-020-01361-z
https://doi.org/10.1186/s13058-020-01361-z
Autor:
Ozlen, Balcioglu, Richard E, Heinz, David W, Freeman, Brooke L, Gates, Berhane M, Hagos, Evan, Booker, Elnaz, Mirzaei Mehrabad, Hyrum T, Diesen, Kishan, Bhakta, Supraja, Ranganathan, Masami, Kachi, Mathias, Leblanc, Peter C, Gray, Benjamin T, Spike
Publikováno v:
Breast Cancer Research : BCR
Background CRIPTO is a multi-functional signaling protein that promotes stemness and oncogenesis. We previously developed a CRIPTO antagonist, ALK4L75A-Fc, and showed that it causes loss of the stem cell phenotype in normal mammary epithelia suggesti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::e3335b4b1b36cdf76cfde38ec7c48d47
https://pubmed.ncbi.nlm.nih.gov/33187540
https://pubmed.ncbi.nlm.nih.gov/33187540